At a glance
- Originator Tanabe Seiyaku
- Class Cardiotonics
- Mechanism of Action Beta 1 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure; Ischaemic heart disorders